Influence of levothyroxine treatment on serum levels of soluble Fas (CD95) and Fas Ligand (CD95L) in chronic autoimmune hypothyroidism

Endocrine

Volumn 38, Issue 3, 2010, Pages 406-411

  Iraj, Nabipour ^a   Kalantarhormozi, Mohammadreza ^a   Assadi, Majid ^a   Jafari, Seyed M ^a   Mohammad, Gharibi ^a   Ahmadi, Esmaeil ^a   Sanjdideh, Zahra ^a  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fas; FasL; Hypothyroidism; Immunity; Levothyroxine; Thyroiditis

Indexed keywords

AUTOANTIBODY; FAS ANTIGEN; FAS LIGAND; LEVOTHYROXINE; THYROGLOBULIN ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; AUTOIMMUNE DISEASE; BLOOD LEVEL; CHRONIC DISEASE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EUTHYROIDISM; FEMALE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT DURATION;

EID: 79951658231     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-010-9401-x     Document Type: Article

References (39)

1. S. Nagata, P. Golstein, Science 267, 1449-1456 (1995)
2. A. Strasser, P.J. Jost, S. Nagata, Immunity 30, 180-192 (2009)
3. G. Stassi, A. Zeuner, D. Di Liberto et al., Clin. Immunol. 21, 19-23 (2001)
4. M. Andrikoula, A. Tsatsoulis, Eur. J. Endocrinol. 144, 561-568 (2001)
5. L.J. Hammond, F.F. Palazzo, M. Shattock et al., Thyroid 11, 919-927 (2001)
6. L.J. Hammond, M.W. Lowdell, P.G. Cerrano et al., J. Pathol. 182, 138-144 (1997)
7. J. Cheng, T. Zhou, C. Liu et al., Science 263, 1759-1762 (1994)
8. T. Suda, H. Hashimoto, M. Tanaka et al., J. Exp. Med. 186, 2045-2050 (1997)
9. N. Kayagaki, A. Kawasaki, T. Ebata, J. Exp. Med. 182, 1777-1783 (1995)
10. P. Schneider, N. Holler, J.L. Bodmer et al., J. Exp. Med. 187, 1205-1213 (1998)
11. S.H. Wang, J.R. Baker, Thyroid 17, 975-979 (2007)
12. O.A. Sukocheva, D.O. Carpenter, J. Endocrinol. 191, 447-458 (2006)
13. J.B. Laoag-Fernandez, H. Matsuo, H. Murakoshi et al., J. Clin. Endocrinol. Metab. 89, 4069-4077 (2004)
14. M. Ghorbel, I. Seugnet, A.M. Ableitner et al., Neurosci Lett. 231, 127-130 (1997)
15. F. Varga, E. Luegmayr, N. Fratzl-Zelman et al., J. Endocrinol. 160, 57-65 (1999)
16. M. Hara, S. Suzuki, J. Mori et al., Thyroid 10, 1023-1034 (2000)
17. N. Saelim, D. Holstein, E.S. Chocron et al., Apoptosis 12, 1781-1794 (2007)
18. M. Pietrzak, M. Puzianowska-Kuznicka, J. Mol. Endocrinol. 41, 177-186 (2008)
19. H.Y. Lin, H.Y. Tang, A. Shih et al., Steroids 72, 180-187 (2007)
20. H.Y. Lin, H.Y. Tang, T. Keating et al., Carcinogen 29, 62-69 (2008)
21. T.H. Brix, K.O. Kyvik, L. Hegedü J. Clin. Endocrinol. Metab. 85, 536-539 (2000)
22. World Health Organization, United Nations Children's Fund, International Council for Control of Iodine Deficiency Disorders, Assessment of the Iodine Deficiency Disorders and Monitoring their Elimination. (World Health Organization, Geneva, 2001), WHO document WHO/NHD/01.1
23. Y. Shimaoka, Y. Hidaka, M. Okumura et al., Thyroid 8, 43-47 (1998)
24. Y. Hiromatsu, T. Bednarczuk, E. Soyejima et al., Thyroid 9, 341-345 (1999)
25. C.Y. Wang, W.B. Zhong, T.C. Chang et al., Metabolism 51, 769-773 (2002)
26. F. Rogowski, A. Parfieńczyk, A. Sopotyk et al., Nucl. Med. Rev. Cent. East Eur. 7, 117-122 (2004)
27. W. Zhao, B.L. Gao, M. Tian et al., J. Clin. Invest. Med. 32, E158-E165 (2009)
28. K. Maeda, Y. Ohara, M. Hashimoto, Clin. Ophthalmol. 2, 609-612 (2008)
29. L. Xerri, E. Devilard, J. Hassoun et al., Mol. Pathol. 50, 87-91 (1997)
30. S. Fountoulakis, G. Vartholomatos, N. Kolaitis et al., Eur. J. Endocrinol. 158, 853-859 (2008)
31. J. Myśliwiec, M. Okota, A. Nikolajuk, Adv. Med. Sci. 51, 119-122 (2006)
32. J. Mysliwiec, M. Oklota, A. Nikolajuk et al., Immunol. Invest. 36, 247-257 (2007)
33. J. Feldkamp, E. Pascher, M. Schott et al., Clin. Endocrinol. Metab. 86, 4250-4253 (2001)
34. K. Ohtsuka, M. Hashimoto, Br. J. Ophthalmol. 84, 103-106 (2000)
35. J. Myśliwiec, A. Kretowski, A. Stepień et al., Pol. Merkur. Lekarski. 17, 368-370 (2004)
36. M. Andrikoula, N. Kolaitis, G. Vartholomatos et al., Immunol. Invest. 38, 398-407 (2009)
37. K. Kolomecki, P. Maciaszczyk, H. Stepien et al., Bratisl. Lek. Listy. 106, 297-300 (2005)
38. B. Rapoport, S.M. McLachlan, J. Clin. Invest. 108, 1253-1259 (2001)
39. L. Hegedüs, J.M. Hansen, U. Feldt-Rasmussen, Clin. Endocrinol. 35, 235-238 (1991